Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-06-10 Sale |
2023-02-27 5:10 pm |
CinCor Pharma Inc. | CINC | Freeman Mason Chief Medical Officer |
40,006 | $0.00228 | $91 | 0 (Indirect Direct) |
View |
| 2022-01-11 Purchase |
2022-01-13 4:28 pm |
CinCor Pharma Inc. | CINC | Freeman Mason EVP Clinical Development |
2,600 | $16 | $41,600 | 2,600 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-02-24 Equity Swap |
2023-02-27 5:10 pm |
N/A N/A |
CinCor Pharma Inc. | CINC | Freeman Mason Chief Medical Officer |
2,594 | $0 | 0 (Direct) |
View |
| 2023-01-26 Option Award |
2023-01-30 8:03 pm |
N/A N/A |
CinCor Pharma Inc. | CINC | Freeman Mason Chief Medical Officer |
40,000 | $0 | 42,600 (Direct) |
View |
Ownership |
2022-01-06 8:49 pm |
N/A 2029-09-24 |
CinCor Pharma Inc. | CINC | Freeman Mason EVP Clinical Development |
0 | $0 | 295,854 (Direct) |
View |
| 2020-06-09 Option Award |
2020-06-11 4:15 pm |
N/A 2030-06-09 |
scPharmaceuticals Inc. | SCPH | Freeman Mason Director |
6,124 | $0 | 6,124 (Direct) |
View |